Lotus Ventures Inc (CSE:J)  has appointed David Hyde of David Hyde & Associates as an adviser to the company. In addition, David will continue in his role as consultant on the company’s late stage license application before Health Canada. We are delighted to have David remain involved in our exciting future, as he has been instrumental in assisting us to our late-stage status with a Confirmation of Readiness.

About Lotus Ventures


Lotus Ventures Inc. (“Lotus” or the “Company”) has achieved a major milestone with the receipt from Health Canada of the Confirmation of Readiness for a License Under the Access to Cannabis for Medical Purposes Regulations (ACMPR). This represents acceptance of our detailed application. Lotus’ construction of its 22,500-square foot purpose-built indoor growing facility in Armstrong, B.C. is in full force and will be completed in August 2018. The company has sufficient capital to finish the construction of the facility, and to exercise its option to acquire the 23 acre Armstrong property in June 2018. The next milestone is receipt of the Cultivation Licence which will allow Lotus to begin growing cannabis. This will be granted once construction is finished and then a “Sale License” will be issued after the first two crops have been grown successfully.

About David Hyde & Associates

David Hyde & Associates is a full-service cannabis security & licensing advisory service based in Toronto & operating internationally. The firm offers security & strategic licensing advisory services based upon a defensible framework of applicable laws, regulatory standards and industry best practice. The 13-member David Hyde & Associates team has extensive experience consulting within the regulated cannabis sector in Canada & beyond & is proud to have been the first Associate Member of the Cannabis Canada Association.

About David Hyde

David Hyde, M.Sc. CPC is one of Canada’s top independent security consultants. He’s an industry-recognized leader & trusted senior advisor to many large organizations. Over a 32-year career, David has operated an award-winning business, secured some of Canada’s most iconic landmarks & led the security program for a $19 billion global corporation with 60 million sq. ft. of facility assets. He is one of only 4 Canadians to be accepted as a member of the world-renowned International Association of Professional Security Consultants (IAPSC).

David holds a M.Sc. (w/Distinction) in Security & Risk Management from the University of Leicester and Certificate in Security Management from the University of Calgary. He completed The Wharton School Development Program for Security Executives and is a Certified Advanced Level Crime Prevention (CPTED) Practitioner. David is a sought- after writer, speaker & thought leader within Canada’s cannabis industry. He is the only Canadian member on the Security Committee for the Foundation of Cannabis Unified Standards.

Over the past 5 years, David and his team have worked on over 290 licensed producer (LP) and licensed dealer (LD) applications under the MMPR/ACMPR/NCR, including 57 of the 104 currently-licensed LPs.

ON BEHALF OF THE BOARD Lotus Ventures Inc. “Dale McClanaghan” Dale McClanaghan, President and CEO

For further information: Dale McClanaghan: dalemcclanaghan@gmail.com (604) 644-9844 or Daniel McRobert, Communications danielmcrobertt@gmail.com (604) 842-4625

Click here to connect with Lotus Ventures Inc (CSE:J) and receive an Investors Presentation. 

 

Source: www.stockwatch.com

Recap of special management call includes upcoming corporate milestones and details of proposed combination with established beverage manufacturer

Emerging leader in infused cannabis beverages, BevCanna Enterprises Inc. (CSE:BEV, OTCQB:BVNNF, FSE:7BC) (“BevCanna” or the “Company”) is pleased to provide a recorded recap of the special management call held on Tuesday November 24, 2020. The call discussed upcoming corporate milestones and reviewed recent developments at the developer and manufacturer of cannabinoid‐infused beverages and consumer products for in‐house brands and white label clients.

Keep reading... Show less

Strong Innovation Pipeline Continues to Drive Market Share Growth
Broken Coast’s First Foray into Cannabis 2.0
Solei Introduces First Limited Release Vape on the Market
Solei, RIFF, Good Supply and B!NGO Expand Product Offerings

Aphria Inc. (” Aphria ” or the ” Company “) ( TSX: APHA and NASDAQ: APHA ), a leading global cannabis company inspiring and empowering the worldwide community to live their very best life, today announced the expansion of its 510 Vape offering across its award-winning adult-use brand portfolio.

Keep reading... Show less

Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Aurora Cannabis Inc. (NYSE: ACB) between February 13, 2020 and September 4, 2020, inclusive (the “Class Period”). If you wish to serve as lead plaintiff, you must move the Court before the December 1 2020 DEADLINE . A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

To join the class action, go to http://zhanginvestorlaw.com/join-action-form/?slug=aurora-cannabis-inc&id=2437 or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email info@zhanginvestorlaw.com for information on the class action.

Keep reading... Show less

Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (“Nextleaf Solutions“, “OILS”, or the “Company”), Canada’s most innovative cannabis extractor, is pleased to provide the following commercial and intellectual property update:

Cannabis Extraction Agreement with White Label Producer

Keep reading... Show less

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES

Khiron Life Sciences Corp. (“ Khiron ” or, the “ Company ”) (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, is pleased to announce that it has closed today its previously announced “bought deal” short form prospectus offering of units (“ Unit s ”), including the exercise in full of the over-allotment option (the “ Offering ”).

Keep reading... Show less